More than 15 million people worldwide are living with spinal cord injury (SCI), which can affect their sensory and motor ...
17h
GlobalData on MSNLineage begins study of OPC1 delivering device for spinal cord injury treatmentAn allogeneic stem cell-derived transplant, OPC1 helps restore or increase the functional activity in SCI patients. It is tailored to replace the spinal cord cells that are either ...
Safety Study of Stem Cell-derived Transplant Includes Subacute and Chronic SCI Patients. CARLSBAD, CA, USA I 11, 2025 I Lineage Cell Therapeutics, Inc. (NYSE American and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results